MSN Laboratories Private Limited — Rosuvastatin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Rosuvastatin · $58.9M export value · DGFT Verified
MSN Laboratories Private Limited is the #2 Indian exporter of Rosuvastatin with $58.9M in export value and 1,632 verified shipments. MSN Laboratories Private Limited holds a 12.7% market share in Rosuvastatin exports across 31 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Rosuvastatin Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Rosuvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $25.9M | 688 | 64.8% |
| COLOMBIA | $3.4M | 115 | 8.5% |
| UNITED KINGDOM | $2.2M | 159 | 5.4% |
| UNITED STATES OF AMERICA | $1.4M | 29 | 3.5% |
| NETHERLANDS | $1.2M | 93 | 3.1% |
| MAURITIUS | $1.2M | 41 | 3.0% |
| MALTA | $1.1M | 138 | 2.7% |
| PHILIPPINES | $668.8K | 17 | 1.7% |
| SRI LANKA | $456.2K | 60 | 1.1% |
| CROATIA | $381.4K | 24 | 1.0% |
MSN Laboratories Private Limited exports Rosuvastatin to 35 countries. The largest destination is UNITED STATES accounting for 64.8% of MSN Laboratories Private Limited's Rosuvastatin shipments, followed by COLOMBIA (8.5%) and UNITED KINGDOM (5.4%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rosuvastatin from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | UNITED STATES | $24.1M | 834 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $5.0M | 130 |
| MSN LABORATORIES EUROPE LIMITED., | UNITED KINGDOM | $946.3K | 31 |
| TO THE ORDER | SRI LANKA | $878.3K | 45 |
| MSN LABS AMERAICAS SAS | COLOMBIA | $767.9K | 20 |
| SCOTT HEALTH LTD | MAURITIUS | $623.4K | 16 |
| VIVANTA GENERICS | NETHERLANDS | $517.6K | 54 |
| MSN LABS AMERICAS SASNIT | COLOMBIA | $439.4K | 14 |
| PRIORITY HEALTHCARE DISTRIBUTIONDBA CURASCRIPT SD | UNITED STATES | $436.4K | 10 |
| PRIORITY HEALTHCARE DISTRIBUTION | UNITED STATES | $400.0K | 8 |
MSN Laboratories Private Limited supplies Rosuvastatin to 100 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by NOVADOZ PHARMACEUTICALS LLC (UNITED STATES) and MSN LABORATORIES EUROPE LIMITED., (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rosuvastatin Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $321.1M worth of Rosuvastatin through 13,477 shipments from 427 suppliers to 143 countries, serving 1,314 buyers globally. MSN Laboratories Private Limited contributes $58.9M to this total, accounting for 12.7% of India's Rosuvastatin exports. MSN Laboratories Private Limited ships Rosuvastatin to 35 countries through 100 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Rosuvastatin Exports?
MSN Laboratories Private Limited's average Rosuvastatin shipment value is $36.1K per consignment, based on 1,632 shipments totaling $58.9M. The largest destination is UNITED STATES (64.8% of MSN Laboratories Private Limited's Rosuvastatin exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Rosuvastatin Exporters?
MSN Laboratories Private Limited ranks #2 among 427 Indian Rosuvastatin exporters with a 12.7% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($58.9M), GLENMARK PHARMACEUTICALS LIMITED ($44.3M), BIOCON PHARMA LIMITED ($32.6M). MSN Laboratories Private Limited processed 1,632 shipments to 31 destination countries.
What Rosuvastatin Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MSN PHARMA ROSUVASTATIN TABLETS USP 20MG | $5.3M | 129 |
| (MSN LABORATORIES) ROSUVASTATIN CALCIUM | $1.7M | 43 |
| MSN PHARMA ROSUVASTATIN TABLETS USP 5MG | $1.7M | 45 |
| MSN PHARMA ROSUVASTATIN TABLETS USP 40MG | $1.6M | 42 |
| MSN PHARMA ROSUVASTATIN TABLETS USP 10MG | $985.4K | 37 |
| DISMIGRAS 40 (ROSUVASTATIN 40MG) 3X10 | $658.7K | 24 |
| (MSN LABORATORIES) ROSUVASTATIN TABLETS | $550.0K | 11 |
| MSN PHARMA ROSUVASTATIN TABLETS USP 20MG1X1000'S | $550.0K | 11 |
| ROSUVASTATIN TAB 20 X 28'S MG MSN UK | $540.5K | 20 |
| MSN FORMULATIONS PRODUCT: ROSUVASTATIN | $490.2K | 10 |
MSN Laboratories Private Limited exports 600 distinct Rosuvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MSN PHARMA ROSUVASTATIN TABLETS USP 20MG with 129 shipments worth $5.3M.
Regulatory Requirements: Exporting Rosuvastatin to Key Markets
What MSN Laboratories Private Limited must comply with to export Rosuvastatin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Rosuvastatin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MSN LABORATORIES PRIVATE LIMITED ★ | $58.9M | 1,632 | 31 | $36.1K |
| 3 | GLENMARK PHARMACEUTICALS LIMITED | $44.3M | 951 | 8 | $46.6K |
| 4 | BIOCON PHARMA LIMITED | $32.6M | 652 | 9 | $50.0K |
MSN Laboratories Private Limited ranks #2 among 427 Indian Rosuvastatin exporters. Average shipment value of $36.1K compared to the market average of $751.9K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and BIOCON PHARMA LIMITED.
Which Indian Ports Ship Rosuvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,090 | 8.1% |
| SAHAR AIR | 921 | 6.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 909 | 6.7% |
| HYDERABAD ICD (INSNF6) | 878 | 6.5% |
| DELHI AIR CARGO ACC (INDEL4) | 769 | 5.7% |
| JNPT/ NHAVA SHEVA SEA | 699 | 5.2% |
| DELHI AIR | 635 | 4.7% |
| HYDERABAD ICD | 550 | 4.1% |
What Other Cardiovascular Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Rosuvastatin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Rosuvastatin, top products include Atorvastatin, Ras, Oseltamivir, Calcium, Losartan. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rosuvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rosuvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,632 individual customs records matching MSN Laboratories Private Limited exporting Rosuvastatin, covering 600 formulations to 35 countries via 100 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 143+ countries, 1,314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rosuvastatin Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Rosuvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Rosuvastatin Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rosuvastatin. For current shipment-level data, contact TransData Nexus.